United Guardian Inc (UG) 15.90 $UG 19.4% Return Seen to

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
United Guardian Inc (UG) 15.90 $UG

19.4% Return Seen to Date on SmarTrend United-Guardian Call (UG)
Comtex SmarTrend(R) - Wed Jun 29, 1:35PM CDT
SmarTrend identified a Downtrend for United-Guardian (NASDAQ:UG) on April 5th, 2016 at $20.23. In approximately 3 months, United-Guardian has returned 19.41% as of today's recent price of $16.30.
UG: 15.90 (-0.19)

United-Guardian Announces Mid-Year Dividend
GlobeNewswire - Fri May 20, 8:00AM CDT
United-Guardian, Inc. (NASDAQ:UG) announced today that the company's Board of Directors, at its meeting on May 18, 2016, declared a cash dividend of $0.35 per share, to be paid on June 15, 2016 to all stockholders of record as of the close of business on June 1, 2016. This will be the 21 consecutive year that the company has paid a dividend.
UG: 15.90 (-0.19)

United-Guardian Reports First Quarter Results
GlobeNewswire - Fri May 13, 8:00AM CDT
United-Guardian, Inc. (NASDAQ:UG) reported today that, as expected, net sales for the first quarter of 2016 were down compared with last year's first quarter, decreasing from $4,372,393 in 2015 to $2,262,576 in the first quarter of 2016. As a result, net income decreased from $1,460,510 ($0.32 per share) in the first quarter of 2015 to $525,091 ($0.11 per share) for the first quarter of 2016.
UG: 15.90 (-0.19)

United-Guardian posts 4Q profit
Automated Insights - Thu Mar 24, 8:15AM CDT
HAUPPAUGE, N.Y. (AP) _ United-Guardian Inc. (UG) on Thursday reported fourth-quarter earnings of $418,000.
UG: 15.90 (-0.19)

United-Guardian Reports Year-End Earnings and Appointment of New Director
GlobeNewswire - Thu Mar 24, 8:00AM CDT
United-Guardian, Inc., (NASDAQ:UG) reported today that net sales for FY-2015 were up 4.1% over last year, increasing from $13,449,679 in 2014 to $14,006,244 in 2015. Net income was also up, increasing from $4,050,416 ($0.88 per share) in 2014 to $4,606,929 ($1.00 per share) in 2015.
UG: 15.90 (-0.19)

United-Guardian Receives FDA Approval to Market New Single-Dose Form of Renacidin(R)
GlobeNewswire - Mon Jan 04, 8:00AM CST
United-Guardian, Inc. (NASDAQ:UG) announced today that it has received FDA approval of its Supplemental New Drug Application to market a new single-dose form of Renacidin (Citric Acid, Glucono delta-Lactone, and Magnesium Carbonate), the company's proprietary irrigating solution that is used to prevent and dissolve calcifications in indwelling catheters. The newly-approved drug product will be supplied in a 30mL single-use plastic bottle, and will replace the company's 500mL glass bottle. The company expects to have the new product available for distribution in March or April 2016.
UG: 15.90 (-0.19)

United-Guardian Announces Year-End Dividend
GlobeNewswire - Fri Nov 20, 8:00AM CST
United-Guardian, Inc. (Nasdaq:UG) announced today that its Board of Directors, at its meeting on November 18, 2015, declared a cash dividend of $0.50 per share, payable on December 15, 2015 to all stockholders of record on December 1, 2015. This brings to $1.00 per share the dividends the company has paid to its stockholders this year.
UG: 15.90 (-0.19)

United-Guardian Reports Strong Third Quarter Results
GlobeNewswire - Mon Nov 09, 8:00AM CST
United-Guardian, Inc. (NASDAQ:UG) reported today that sales for the third quarter of 2015 increased by 44%, and net income increased by almost 200%, compared with the same period last year. Sales for the three-month period were $3,620,365, compared with $2,516,620 for the third quarter of 2014. Net income for the three-month period increased to $1,217,537 ($0.26 per share) from $411,426 ($0.09 per share) for the same period in 2014. For the nine months ended September 30, 2015 sales increased to $12,116,849 as compared with $9,456,248 for the same period last year (an increase of 28%), and net income increased to $4,188,558 ($0.91 per share) from $2,648,452 ($0.58 per share) in 2014, a 58% increase.
UG: 15.90 (-0.19)

United-Guardian Reports Record Six Month Financial Results
GlobeNewswire - Tue Aug 11, 8:00AM CDT
United-Guardian, Inc. (NASDAQ:UG) reported today that sales for the second quarter of 2015 increased by 38% over the same period last year, resulting in a 68% increase in net income compared with the second quarter of 2014. Sales for the quarter increased from $2,980,136 in 2014 to $4,124,091 this year, and net income increased from $901,273 ($0.20 per share) in 2014 to $1,510,511 ($0.33 per share) this year, resulting in the strongest second quarter in the company's history. For the first six months of 2015 sales increased 22% from $6,939,628 in 2014 to $8,496,484 this year, and net income increased 33% from $2,237,026 ($0.49 per share) to $2,971,021 ($0.65 per share), both new company records.
UG: 15.90 (-0.19)

United-Guardian Has Returned 12.5% Since SmarTrend Recommendation (UG)
Comtex SmarTrend(R) - Thu Jun 04, 9:39AM CDT
SmarTrend identified an Uptrend for United-Guardian (NASDAQ:UG) on May 20th, 2015 at $20.28. In approximately 2 weeks, United-Guardian has returned 12.50% as of today's recent price of $22.81.
UG: 15.90 (-0.19)

United-Guardian Announces Increase in Mid-Year Dividend
GlobeNewswire - Fri May 15, 8:00AM CDT
United-Guardian, Inc. (Nasdaq:UG) announced today that the company's Board of Directors, at its meeting on May 13, 2015, declared a cash dividend of $0.50 per share, a 4% increase over last year's mid-year dividend, and a 56% increase over the year-end dividend the company paid in the second half of 2014. It also equals the largest semi-annual dividend the company has ever paid. The dividend will be paid on June 15, 2015 to all stockholders of record as of the close of business on June 1, 2015. This will be the 20 consecutive year that the company has paid a dividend.
UG: 15.90 (-0.19)

Consumer Goods Sector in Focus: Complementary Research on DT Asia Investments, Zuoan Fashion, Embotelladora Andina, G. Willi-Food International, and United-Guardian Inc.
PR Newswire - Fri May 15, 7:40AM CDT
Editor Note: For more information about this release, please scroll to bottom.
CADT: 7.24 (+2.25), ZA: 1.40 (-0.01), AKO.B: 23.72 (+0.04), UG: 15.90 (-0.19), WILC: 4.24 (unch)

United-Guardian Reports Record First Quarter Sales
GlobeNewswire - Wed May 06, 12:00PM CDT
United-Guardian, Inc. (Nasdaq:UG) reported today that sales in the first quarter of 2015 were the strongest of any first quarter in its history, and were just short of its best performing quarter ever. Net sales for the quarter increased by 10.4% compared with the first quarter of 2014, and earnings were up by 9%, resulting in an increase in earnings per share from $0.29 in 2014 to $0.32 this year.
UG: 15.90 (-0.19)

United-Guardian Reports Year-End Earnings
GlobeNewswire - Mon Mar 23, 8:00AM CDT
United-Guardian, Inc., (Nasdaq:UG) announced today that strong fourth quarter sales helped boost the company's earnings for the year to $4.1 million ($0.88 per share) on sales of $13.4 million. While earnings for the year were lower than last year's record earnings of $5.9 million ($1.28 per share) on sales of $15.4 million, strong overseas sales in the fourth quarter helped to offset some of the weakness the company experienced in the third quarter of 2014.
UG: 15.90 (-0.19)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 5

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 3

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 6

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 4

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 5

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 9

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 3

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading

Top 5 Most Recently Viewed Articles

Huggies and Walgreens Uniting to Tackle Diaper Need

Updated Category News Views 300

Partnering to Tackle Diaper Needs Huggies and Walgreens are thrilled to kick off a meaningful initiative designed to support families dealing with diaper need. For each pack of Huggies Diapers bought at Walgreens, either in stores or online, Huggies will donate a day's worth of diapers to the National Diaper Bank Network, aiming to contribute as many as one million...

Continue Reading
Surging Growth of Fatty Methyl Ester Sulfonate Market By 2033

Updated Category News Views 144

Exploring the Future of the Fatty Methyl Ester Sulfonate Market The dynamic world of the fatty methyl ester sulfonate (FMES) market is entering an exciting phase of growth. Beginning at an estimated value of US$ 805.9 million in 2024, the forecast projects the market to surge to US$ 2,095.1 million by 2033. This impressive leap represents an annual growth rate of 11.20%,...

Continue Reading
Biden Administration Approves Perpetua's Mining Project

Updated Category News Views 151

Biden Administration Approves Perpetua's Mining Project In a significant move for resource management and economic development, the Biden administration has granted the final mining permit for Perpetua Resources' antimony and gold mine located in Idaho. This decision comes in response to concerns regarding China's substantial control over the global market for antimony, a...

Continue Reading
Neurocrine Biosciences Set to Share Q2 2025 Financial Insights

Updated Category News Views 130

Neurocrine Biosciences Announces Upcoming Financial Conference Call Neurocrine Biosciences, Inc. (NASDAQ: NBIX), a leader in the field of neuroscience, is excited to inform stakeholders about its scheduled conference call and webcast. The event is set for the afternoon of July 30, where financial results for the second quarter of 2025 will be shared. This moment allows...

Continue Reading
Societe Generale Updates on Universal Registration Document

Updated Category News Views 127

Introducing the Second Amendment Societe Generale has exciting news regarding the second amendment to its 2025 Universal Registration Document. This essential document plays a crucial role in ensuring transparency and compliance with regulatory frameworks. The amendment was officially filed with the French Financial Markets Authority (AMF), ensuring that all stakeholders...

Continue Reading